Login

Basil Karampelas discusses ClearVue Technologies Ltd.'s vision and progress in an interview with The Market Herald. 00:10:00

Share On Facebook Share On Twitter

Tommy Logtenberg is the CEO of The Market Herald.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Dr. Francis Wedin Debunks Myths About Direct Lithium Extraction | Francis Wedin , CEO, Vulcan Energy Resources Ltd.
00:10:00
Vinod Khosla and Khosla Ventures' Impact on Energy and Technology | Vinod Khosla, CEO, Khosla Venture.
00:10:00
Ares Management's Strategic Growth: Private Credit and Middle Market Opportunities | Michael Arougheti, CEO , Ares Management.
00:10:00
Empowering Young Talent: Harold Boël's Commitment to Vocatio Laureates| Harold Boël, CEO, Sofina.
00:10:00
Exploring Innovations in Learning and Curriculum Development
00:10:00
John B. Wood, CEO of Telos, highlights the strategic partnership with AWS as a means to enhance cybersecurity solutions through scalable cloud-based services.
00:10:00
WISeKey CEO, Carlos Moreira had an interview with NASDAQ | Carlos Creus Moreira, CEO, Wisekey International Holding AGWKEY:NMQ
00:10:00
Interview with Phil Mesman, CFA | Insights on Fixed Income Strategies and Industry Predictions | Scott Starratt - Senior Portfolio Manager of Starratt Wealth Management
00:10:00
Vanguard CEO Tim Buckley: Keep Going Despite Market Chaos | Tim Buckley, CEO, Aeffe SpA
00:10:00
Mustang Resources: Advancing Ruby and Graphite Projects in Mozambique
00:10:00
Philippine Economy: Challenges and Opportunities| president , Ayala Corporation
00:10:00
The Schneiders sold promissory notes to RBC Dominion Securities Corp and Highland Capital Management through their agent Glen Rauch.

© 2017 - Neuhu+